Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 17, 2021 FORM 4 SUBMISSION
S-3ASR Mar 5, 2021 S-3ASR
S-8 Mar 5, 2021 S-8
10-K Mar 3, 2021 10-K
8-K Mar 3, 2021 8-K
4 Feb 22, 2021 FORM 4 SUBMISSION
3 Feb 22, 2021 FORM 3 SUBMISSION
8-K Feb 19, 2021 8-K
4 Feb 18, 2021 FORM 4 SUBMISSION
4 Feb 18, 2021 FORM 4 SUBMISSION
4 Feb 18, 2021 FORM 4 SUBMISSION
4 Feb 18, 2021 FORM 4 SUBMISSION
4 Feb 18, 2021 FORM 4 SUBMISSION
4 Feb 18, 2021 FORM 4 SUBMISSION
8-K Feb 17, 2021 8-K
SC 13G/A Feb 12, 2021 AMENDMENT NO. 1 TO SCHEDULE 13G
SC 13G Feb 11, 2021 SC 13G
SC 13G Feb 9, 2021 SCHEDULE 13G
SC 13G/A Feb 8, 2021
SC 13D/A Jan 28, 2021 AMENDMENT NO. 1
SC 13D/A Jan 27, 2021 SC 13D/A
4 Jan 22, 2021 FORM 4 SUBMISSION
424B1 Jan 22, 2021 424B1
EFFECT Jan 21, 2021
CORRESP Jan 19, 2021
← Newer Page 14 of 18 · 443 filings Older →